4//SEC Filing
Froimson Mark 4
Accession 0001209191-22-028275
CIK 0001396814other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:13 PM ET
Size
5.3 KB
Accession
0001209191-22-028275
Insider Transaction Report
Form 4
Froimson Mark
Director
Transactions
- Sale
Common Stock
2022-05-09$59.37/sh−1,000$59,370→ 4,908 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.36 to $59.41, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001709050
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 4:13 PM ET
- Size
- 5.3 KB